Description: Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.
Home Page: www.hiteck.com.cn
Hite Science and Technology Park
Wuhan,
430056
China
Phone:
86 27 8489 1666
Officers
| Name | Title |
|---|---|
| Mr. Ya Chen | Chairman & GM |
| Ms. Han Zhen Xia | CFO & Director |
| Mr. Huang Chen | Deputy GM, Sec. & Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 164.5652 |
| Price-to-Book MRQ: | 2.0505 |
| Price-to-Sales TTM: | 6.555 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1143 |